Renin-angiotensin system inhibitors and troponin elevation in spinal surgery

被引:3
|
作者
McClendon, Jamal, Jr. [1 ]
Smith, Timothy R. [1 ]
Thompson, Sara E. [1 ]
Sugrue, Patrick A. [2 ]
Sauer, Andrew J. [3 ]
O'Shaughnessy, Brian A. [4 ]
Carabini, Louanne [5 ]
Koski, Tyler R. [1 ]
机构
[1] NW Mem Hosp, Dept Neurol Surg, Chicago, IL 60611 USA
[2] Washington Univ, Dept Orthoped Surg, St Louis, MO USA
[3] NW Mem Hosp, Div Cardiol, Dept Internal Med, Chicago, IL 60611 USA
[4] Howell Allen Clin, Nashville, TN USA
[5] NW Mem Hosp, Dept Anesthesiol, Chicago, IL 60611 USA
关键词
Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Hospitalization stay; Myocardial infarction; Spinal fusion; Troponin elevation; CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; II-RECEPTOR BLOCKERS; HEART-FAILURE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; HIGH-RISK; ESSENTIAL-HYPERTENSION;
D O I
10.1016/j.jocn.2013.10.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Renin-angiotensin system (RAS) inhibition by angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) has been shown to reduce cardiovascular mortality and non-fatal myocardial infarction (MI) in high-risk surgical patients. However, their effect in spinal surgery has not been explored. Our objective was to determine the effect of RAS inhibitors on postoperative troponin elevation in spinal fusions, and to examine their correlation with hospital stay. We retrospectively analyzed 208 consecutive patients receiving spinal fusions >= 5 levels between 2007-2010 with a mean follow-up of 1.7 years. Inclusion criteria were age >= 8 years, elective fusions for kyphoscoliosis, and semi-elective fusions for tumor or infection. Exclusion criteria were trauma and follow-up <1 year. Descriptives, frequencies, and logistic and linear regression were used to analyze troponin elevation (>= 0.04 ng/mL), peak troponin level, and hospital stay. The results featured 208 patients with a mean body mass index (BMI) 28.5 kg/m(2) who underwent 345 spinal fusions. ACEI/ARB were withheld the day prior to surgery in 121 patients with 11 patients noteworthy for intra-operative electrocardiogram changes, 126 patients with troponin elevation, and 14 MI identified prior to discharge. Multivariate logistic regression identified BMI (p = 0.04), estimated blood loss (p = 0.015), and preoperative ACEI/ARB (p = 0.015, odds ratio = 2.7) as significant independent predictors for postoperative troponin elevation. Multivariate linear regression showed preoperative Oswestry Disability Iridex (p = 0.002), unplanned return to operating room (p = 0.007), pneumonia prior to hospital discharge (p < 0.01), and preoperative ACEI/ARB to be associated with hospital stay. In patients with spinal fusions >= 5 levels, ACEI/ARB are independently associated with postoperative troponin elevation and increased hospital stay. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1133 / 1140
页数:8
相关论文
共 50 条
  • [1] Preoperative Renin-Angiotensin System Inhibitors Protect Renal Function in Aging Patients Undergoing Cardiac Surgery
    Barodka, Viachaslau
    Silvestry, Scott
    Zhao, Ning
    Jiao, Xiangyin
    Whellan, David J.
    Diehl, James
    Sun, Jian-Zhong
    JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) : E63 - E69
  • [2] Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery
    Ding, Qian
    Zhang, Zugui
    Liu, Hong
    Nie, Huang
    Berguson, Mark
    Goldhammer, Jordan E.
    Young, Nilas
    Boyd, Douglas
    Morris, Rohinton
    Sun, Jianzhong
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction
    Maitland-van der Zee, Anke-Hilse
    van Wieren-de Wijer, Diane B. M. A.
    de Boer, Anthonius
    Kroon, Abraham A.
    de Leeuw, Peter W.
    Schiffers, Paul
    Janssen, Rob G. J. H.
    Psaty, Bruce M.
    van Duijn, Cornelia M.
    Stricker, Bruno H. Ch
    Klungel, Olaf H.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2011, 12 (03) : 208 - 214
  • [4] New modalities of renin-angiotensin system inhibition: Renin inhibitors and active immunization against angiotensin II
    Azizi, M.
    REVUE DE MEDECINE INTERNE, 2010, 31 (10): : 659 - 664
  • [5] Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis
    Angriman, Federico
    Rosella, Laura C.
    Lawler, Patrick R.
    Ko, Dennis T.
    Martin, Claudio M.
    Wunsch, Hannah
    Scales, Damon C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (03) : 414 - 423
  • [6] Renin-Angiotensin System Blocking Drugs
    Roberto Robles, Nicolas
    Cerezo, Isis
    Hernandez-Gallego, Roman
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (01) : 14 - 33
  • [7] Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD
    Shulman, Rachel S.
    Yang, Wei
    Cohen, Debbie L.
    Reese, Peter P.
    Cohen, Jordana B.
    HYPERTENSION, 2024, 81 (10) : 2082 - 2090
  • [8] Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment
    Avci, Burcak Kilickiran
    Ikitimur, Baris
    Karadag, Bilgehan
    Karadag, Bilgehan
    Ongen, Zeki
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 : S1 - S8
  • [9] Inflammation and Atherosclerosis: The Role of Renin-Angiotensin System and Its Inhibition
    Partigulova, A. S.
    Naumov, V. G.
    KARDIOLOGIYA, 2010, 50 (10) : 50 - 55
  • [10] Renin-angiotensin system inhibitors and angioedema: anesthetic implications
    Stojiljkovic, Ljuba
    CURRENT OPINION IN ANESTHESIOLOGY, 2012, 25 (03) : 356 - 362